logo-loader
Oxford Biodynamics PLC

'Interest is growing exponentially', says Oxford Biodynamics' Christian Hoyer Millar

Oxford Biodynamics (LON:OBD) CEO Christian Hoyer Millar and CSO Sasha Akoulitchev talk to Proactive's Andrew Scott about the company's platform EpiSwitch as well as the overall strategy and outlook.

Their technology manages biomarkers in people’s blood to help pharmaceutical companies identify which patients will react to certain drugs.

''We've worked with six of the biggest pharma and biotech companies in the world so far. We've undertaken about 23 projects and the interest in what we're doing is growing exponentially'', Hoyer Millar says.

Quick facts: Oxford Biodynamics PLC

Price: £0.95

Market: AIM
Market Cap: £87.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Rockfire Resources' David Price discusses Brigalow Alluvial...

Rockfire Resources PLC's (LON:ROCK) David Price tells Proactive London's Andrew Scott they've been getting a better understanding of an alluvial gold deposit next one of their main assets in Queensland. Calculations made in 1986 on an area known as Brigalow Alluvial Goldfield has suggested...

6 hours, 11 minutes ago

RNS

PDMR Dealing

1 week, 1 day ago

PDMR Dealing

1 week, 2 days ago

PDMR Dealing

2 weeks, 4 days ago

PDMR Dealing

3 weeks, 1 day ago

PDMR Shareholding

4 weeks ago

2 min read